Get the Stockscreener App
3.42
0.88%
0.03
After Hours:
3.40
-0.02
-0.58%
Envveno Medical Corporation Stock (NVNO) Forecast
The Envveno Medical Corporation (NVNO) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.1287, representing a -67.00% decrease from the current price of $3.42. The highest analyst price target is $1.5839, and the lowest is $0.6735.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NVNO Price Target
Average 2.5611
(-25.11% Downside)
Is Envveno Medical Corporation (NVNO) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 44.54 | Neutral |
| STOCH(9,6) | 49.43 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -0.1524 | Buy |
| ADX(14) | 29.99 | Sell |
| William %R | -33.96 | Neutral |
| CCI(14) | 43.62 | Neutral |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.382
Buy
|
3.3802
Buy
|
| MA20 |
3.32
Buy
|
3.4463
Sell
|
| MA50 |
4.0962
Sell
|
3.9157
Sell
|
| MA100 |
4.7156
Sell
|
4.3709
Sell
|
| MA200 |
4.9342
Sell
|
4.6214
Sell
|
Buy: 3
Sell: 7
Neutral: 0
Summary: Sell
According to our latest analysis, NVNO could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 9 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on NVNO, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 44.54 indicates that NVNO is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 49.43 indicates that NVNO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that NVNO is oversold. This suggests that NVNO price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 29.99 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 43.62 indicates that NVNO is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term NVNO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Envveno Medical Corporation financial reports and earnings history, Envveno Medical Corporation (NVNO) stock could reach $1.3822 by 2030, $11.96 by 2040 and $13.39 by 2050. See the projected annual prices until 2050 of the Envveno Medical Corporation stock below:
- Envveno Medical Corporation (NVNO) is expected to reach an average price of $4.4062 in 2035, with a high prediction of $5.1198 and a low estimate of $4.9862. This indicates an $28.84% rise from the last recorded price of $3.42.
- Envveno Medical Corporation (NVNO) stock is projected to chart a bullish course in 2040, with an average price target of $11.89, representing an $247.53% surge from its current level. The forecast ranges from a conservative $12.08 to a sky-high $11.96.
- Our analysts predict Envveno Medical Corporation (NVNO) to jump 530.21% by 2045, soaring from $21.38 to an average price of $21.55, potentially reaching $21.25. While $21.38 is the low estimate, the potential upside is significant.
- Envveno Medical Corporation (NVNO) stock is expected to climb by 2050, reaching an average of $13.76, a $302.23% jump from its current level. However, a wide range of estimates exists, with high and low targets of $13.39 and $13.59, respectively, highlighting the market's uncertainty.
Envveno Medical Corporation Stock (NVNO) Year by Year Forecast
Envveno Medical Corporation Stock (NVNO) Price Forecast for 2024
Our forecast for NVNO stock price in 2024 now indicates an average price target of $3.8217 with a high forecast of $6.97 and a low forecast of $0.6735. The average prediction reflects an increase of +11.75% from the last recorded price of $3.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $0.9673 | $0.6735 | $1.5839 | -71.72% |
Envveno Medical Corporation Stock (NVNO) Price Forecast for 2025
Envveno Medical Corporation Stock (NVNO) is expected to reach an average price of $2.5611 in 2025, with a high prediction of $4.9221 and a low estimate of $0.2001. This indicates an -25.11% fall from the last recorded price of $3.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $0.6596 | $0.2001 | $1.1712 | -80.71% |
| February, 2025 | $2.1975 | $0.5191 | $2.2075 | -35.75% |
| March, 2025 | $2.8953 | $1.4169 | $3.0353 | -15.34% |
| April, 2025 | $4.3226 | $2.6548 | $4.792 | +26.39% |
| May, 2025 | $3.2505 | $2.861 | $4.9221 | -4.96% |
| June, 2025 | $3.3483 | $2.6899 | $3.3789 | -2.10% |
| July, 2025 | $3.0056 | $2.6772 | $3.4578 | -12.12% |
| August, 2025 | $1.6835 | $1.6435 | $3.1446 | -50.78% |
| September, 2025 | $2.0613 | $1.653 | $2.5419 | -39.73% |
| October, 2025 | $2.8687 | $1.9908 | $3.7092 | -16.12% |
| November, 2025 | $2.2881 | $2.2665 | $3.1823 | -33.10% |
| December, 2025 | $2.0938 | $1.8999 | $2.5954 | -38.78% |
Envveno Medical Corporation Stock (NVNO) Price Forecast for 2026
The predicted value for Envveno Medical Corporation (NVNO) in 2026 is set at an average of $2.3972. Estimates vary from a peak of $4.7759 to a trough of $0.0185, indicating an -29.91% surge from the present price of $3.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.9017 | $0.9717 | $2.2033 | -44.40% |
| February, 2026 | $0.5495 | $0.2301 | $1.9786 | -83.93% |
| March, 2026 | $0.5074 | $0.0185 | $0.5224 | -85.16% |
| April, 2026 | $2.3947 | $0.4358 | $2.7252 | -29.98% |
| May, 2026 | $1.7126 | $1.6126 | $3.0842 | -49.93% |
| June, 2026 | $3.2904 | $1.642 | $3.2904 | -3.79% |
| July, 2026 | $2.9477 | $1.8588 | $3.4683 | -13.81% |
| August, 2026 | $2.1656 | $1.4957 | $3.0972 | -36.68% |
| September, 2026 | $1.4629 | $1.064 | $2.745 | -57.23% |
| October, 2026 | $2.5507 | $1.2124 | $3.1413 | -25.42% |
| November, 2026 | $2.0686 | $1.5397 | $2.6902 | -39.51% |
| December, 2026 | $4.0359 | $1.8375 | $4.7759 | +18.01% |
Envveno Medical Corporation Stock (NVNO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Envveno Medical Corporation (NVNO) is $2.3989, with a high forecast of $4.6548 and a low forecast of $0.143. This indicates an -29.86% decrease from the last price of $3.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.4938 | $3.1448 | $4.6548 | +2.16% |
| February, 2027 | $2.5016 | $2.4516 | $3.6532 | -26.85% |
| March, 2027 | $0.8689 | $0.7189 | $3.4911 | -74.59% |
| April, 2027 | $0.6754 | $0.143 | $1.0979 | -80.25% |
| May, 2027 | $0.2397 | $0.4386 | $0.4225 | -92.99% |
| June, 2027 | $1.225 | $0.3107 | $1.035 | -64.18% |
| July, 2027 | $1.622 | $1.6285 | $1.5593 | -52.57% |
| August, 2027 | $1.3636 | $1.6904 | $1.3904 | -60.13% |
| September, 2027 | $1.075 | $0.4468 | $1.2547 | -68.57% |
| October, 2027 | $2.3133 | $1.9701 | $2.0133 | -32.36% |
| November, 2027 | $2.0476 | $2.3365 | $2.1765 | -40.13% |
| December, 2027 | $2.373 | $2.498 | $2.6097 | -30.62% |
Envveno Medical Corporation Stock (NVNO) Price Forecast for 2028
In 2028, Envveno Medical Corporation (NVNO) is projected to reach an average price of $0.9586, with a high projection of $1.9142 and a low estimate of $0.00309. This indicates an -71.97% fall from the last price of $3.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.8772 | $1.1672 | $1.244 | -74.35% |
| February, 2028 | $0.8985 | $0.1485 | $1.1126 | -73.73% |
| March, 2028 | $0.1631 | $0.00309 | $1.9142 | -95.23% |
| April, 2028 | $0.2088 | $0.128 | $0.7909 | -93.89% |
| May, 2028 | $0.1334 | $0.00657 | $0.5256 | -96.10% |
| June, 2028 | $0.0191 | $0.0103 | $0.2691 | -99.44% |
| July, 2028 | $0.5352 | $0.6719 | $0.5741 | -84.35% |
| August, 2028 | $0.6495 | $0.1694 | $0.7295 | -81.01% |
| September, 2028 | $0.2952 | $0.0252 | $0.9284 | -91.37% |
| October, 2028 | $0.6291 | $0.1741 | $0.4394 | -81.60% |
| November, 2028 | $1.2795 | $0.6623 | $1.0945 | -62.59% |
| December, 2028 | $2.0588 | $1.4777 | $1.2488 | -39.80% |
Envveno Medical Corporation Stock (NVNO) Price Forecast for 2029
The 2029 price forecast for Envveno Medical Corporation Stock (NVNO) is $1.2946 on average, with a high prediction of $2.5818 and a low estimate of $0.00734. This represents an -62.15% decrease from the previous price of $3.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.5142 | $2.3509 | $2.1942 | -26.49% |
| February, 2029 | $0.6385 | $2.0724 | $2.0502 | -81.33% |
| March, 2029 | $0.1173 | $0.1306 | $0.5683 | -96.57% |
| April, 2029 | $0.063 | $0.0663 | $0.1939 | -98.16% |
| May, 2029 | $0.0326 | $0.0103 | $0.9596 | -99.05% |
| June, 2029 | $0.3667 | $0.0535 | $1.0565 | -89.28% |
| July, 2029 | $0.891 | $0.5799 | $0.4241 | -73.95% |
| August, 2029 | $0.3036 | $0.3064 | $1.0343 | -91.12% |
| September, 2029 | $0.5207 | $0.00734 | $0.8526 | -84.78% |
| October, 2029 | $0.594 | $0.094 | $0.8387 | -82.63% |
| November, 2029 | $1.9597 | $0.6529 | $2.5818 | -42.70% |
| December, 2029 | $0.8554 | $0.5474 | $2.1686 | -74.99% |
Envveno Medical Corporation Stock (NVNO) Price Forecast for 2030
Envveno Medical Corporation Stock (NVNO) is expected to reach an average price of $3.0464 in 2030, with a high forecast of $5.7596 and a low forecast of $0.3332. This signifies an -10.92% decrease from the last price of $3.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.8577 | $0.3332 | $1.3822 | -74.92% |
| February, 2030 | $3.2148 | $2.20 | $2.7548 | -6.00% |
| March, 2030 | $3.5913 | $3.7364 | $3.1904 | +5.01% |
| April, 2030 | $3.7877 | $3.7161 | $3.4545 | +10.75% |
| May, 2030 | $4.7458 | $4.3793 | $4.5458 | +38.77% |
| June, 2030 | $5.0222 | $5.0106 | $4.889 | +46.85% |
| July, 2030 | $3.3603 | $3.7103 | $4.6738 | -1.75% |
| August, 2030 | $5.1767 | $4.0419 | $4.8467 | +51.37% |
| September, 2030 | $5.4082 | $5.2983 | $5.2199 | +58.13% |
| October, 2030 | $5.6212 | $5.5148 | $5.7596 | +64.36% |
| November, 2030 | $4.0076 | $4.6676 | $5.5239 | +17.18% |
| December, 2030 | $3.2341 | $3.7241 | $4.0593 | -5.44% |
0.47%
1.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):